Percutaneous administration of testosterone gel in postmenopausal women – a pharmacological study

References

• Flöter A, Nathorst-Böös J, Carlstöm K, von Schoultz B. Androgen status and sexual life in perimenopausal women. Menopause 1971;4:95–100.
   Google Scholar
• Nathorst-Böös J, Wildund I, Mattsson L-A, Sandin K, von Schoultz B. Is sexual life influenced by transdermal estrogen therapy - a double blind controlled study in postmenopausal women. Acta Obstet Gynecol Scand 1993;72:656–60.
   Google Scholar
• Sherwin B, Gelfand M, Brender W. Androgen enhances sexual motivation in females: a prospective, crossover study of sex steroid administration in the surgical menopause. Psycho-som Med 1985;47:339–51.
   Google Scholar
• Davis SR, McCloud P, Strauss BJ, Burger H. Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality. Maturitas 1995;2:227–36.
   Google Scholar
• Flöter A, Nathorst-Böös J, Carlström K, von Schoultz B. Addition of testosterone to estrogen replacement therapy in oophorectomized women: effects on sexuality and well-being. Climacteric 2002;5:357–65.
   PubMed Web of Science ®Google Scholar
• Barrett-Connor E, Young R, Notelovitz M, Sullivan J, Wiita B, Hwa-Ming Y, Nolan J. A two year, double-blind comparison of estrogen-androgen and conjugated estrogens in surgically menopausal women. J Reprod Med 1999;44:1012–20.
   Google Scholar
• Watts NB, Notelovitz M, Timmons MC, Addison W, Wiita B, Downey U. Comparison of oral estrogens and estrogens plus androgen on bone mineral density, menopausal symptoms and lipid-lipoprotein profiles in surgical menopause. Obstet Gynecol 1995;85:529–37.
   PubMed Web of Science ®Google Scholar
• Shifren JL, Braunstein GD, Simon JA, Casson PR, Buster JE, Redmond GP, Burki RE, Ginsburg ES, Rosen RC, Leiblum SR, et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 2000;343:682–8.
   PubMed Web of Science ®Google Scholar
• Nieschlag E, Mauss J, Coert A. Plasma androgen levels in men after oral administration of testosterone or testosterone undecanoate. Acta Endocrinol 1975;79:366–74.
   Google Scholar
• Hickok LR, Tommey C, Speroff L. A comparison of esterified estrogens with and without methyltestosterone: effects on endometrial histology and serum lipoproteins in postmeno-pausal women. Obstet Gynecol 1993;82:919–24.
   Google Scholar
• James M, Marty JP, Wepierre J. Localized diffusion of substances absorbed through the skin. C R Acad Sci Hebd Seances Acad Sci D 1974;278:2063–6.
   PubMedGoogle Scholar
• Chanez JF, de Lignieres B, Marty JP, Wepierre J. Influence of the size of the area of treatment on percutaneous absorption of estradiol in the rat. Skin Pharmacol 1989;2:15–21.
   PubMedGoogle Scholar
• Marin P, Krotkiewski M, Bjorntorp P. Androgen treatment of middle-aged, obese men: effects on metabolism, muscle and adipose tissues. Eur J Med 1992;1:329–36.
   Google Scholar
• Gustafsson O, Norming U, Gustafsson S, Eneroth P, Astrom G, Nyman CR. Dihydrotestosterone and levels in men screened for prostate cancer: a case control study of a randomized population. Br J Urol 1996;77:433–40.
   PubMedGoogle Scholar
• Brody S, Carlström K, Lagrelius A, Lunell N-O, Rosenborg L. Serum levels of 4-androstene-3,17-dione in menstruating and postmenopausal women. Evaluation of a radioimmunoas-say and correlation to bone mineral content and endometrial pathology. Acta Obstet Gynecol Scand 1983;62:531–4.
   Google Scholar
• Stege R, Eriksson A, Henriksson P, Carlström K. Orchidect-omy or estrogen treatment in prostatic cancer: effects on serum levels of adrenal androgens and related steroids. Int J Androl 1987;10:581–7.
   Google Scholar
• Sodergdrd R, Bäckström T, Shanbag V, Carstensen H. Calculation of free and bound fractions of testosterone and estradio1-17# to plasma proteins at body temperature. J Steroid Biochem 1982;18:801–4.
   Google Scholar
• Ahmed SR, Boucher AE, Manni A, Santen RJ, Bartholomew M, Demers LM. Transdermal testosterone therapy in the treatment of male hypogonadism. J Clin Endocrinol Metab 1988;66:546–51.
   PubMed Web of Science ®Google Scholar
• Coert A, Geelen J, de Visser J, van der Vies J. The pharmacology and metabolism of testosterone undecanoate (TU), a new orally active androgen. Acta Endocrinol 1975;79:789–800.
   Google Scholar
• Horst HJ, Holtje WJ, Dennis M, Coert A, Geelen J, Voigt KD. Lymphatic absorption and metabolism of orally administered testosterone undecanoate in man. Klin Wochenschr 1976;54:875–9.
   PubMedGoogle Scholar
• Dunn JF, Nisula BC, Rodbard D. Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding glo-bulin in human plasma. J Chin Endocrinol Metab 1981;53: 58–68.
   Google Scholar
• Crilly RG, Francis RM, Nordin BEC. Steroid hormones, ageing and bone. Chin Endocrinol Metab 1981;10:115–39.
   Google Scholar
• Meikle AW, Stringham JD, Wilson DE, Dolman U. Plasma 5 a-reduced androgens in men and hirsute women: role of adrenals and gonads. J Chin Endocrinol Metab 1979;48:969–75.
   PubMedGoogle Scholar
• Lobo RA. Androgens in postmenopausal women: production, possible roles and replacement options. Obstet Gynecol Surv 2001;55:361–76.
   Google Scholar
• Mooradian AD, Morley JE, Korenman SG. Biological actions of androgens. Endocr Rev 1987;8:1–28.
   PubMed Web of Science ®Google Scholar
• Pardridge WM. Serum bioavailability of sex hormones. ClinEndocrinol Metab 1986;15:259–78.
   Web of Science ®Google Scholar
• von Schoultz B, Carlström K. On the regulation of sex hormone-binding globulin — a challenge of an old dogma and outlines of an alternate mechanism. J Steroid Biochem 1989;32:327–34.
   PubMedGoogle Scholar
• Raisz LG, Wiita B, Altis A, Bowen A, Swartz S, Trahotis M, Shoukri K, Smith J. Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women. Clin Endocrinol Metab 1996;81:37–43.
   Google Scholar